Annual Operating Profit
$1.89 M
+$9.06 M+126.43%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual operating income is $1.89 million, with the most recent change of +$9.06 million (+126.43%) on December 31, 2023.
- During the last 3 years, HBIO annual operating profit has risen by +$1.67 million (+757.01%).
- HBIO annual operating profit is now -82.33% below its all-time high of $10.72 million, reached on December 31, 2010.
Performance
HBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.87 M
-$54.00 K-2.97%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly operating income is -$1.87 million, with the most recent change of -$54.00 thousand (-2.97%) on September 30, 2024.
- Over the past year, HBIO quarterly operating profit has dropped by -$941.00 thousand (-100.86%).
- HBIO quarterly operating profit is now -125.47% below its all-time high of $7.36 million, reached on March 31, 2000.
Performance
HBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$5.69 M
-$941.00 K-19.81%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM operating income is -$5.69 million, with the most recent change of -$941.00 thousand (-19.81%) on September 30, 2024.
- Over the past year, HBIO TTM operating profit has dropped by -$6.85 million (-592.73%).
- HBIO TTM operating profit is now -125.79% below its all-time high of $22.07 million, reached on September 30, 2000.
Performance
HBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
HBIO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.4% | -100.9% | -592.7% |
| 3 y3 years | +757.0% | -442.0% | -282.2% |
| 5 y5 years | +92.5% | -107.1% | -409.8% |
HBIO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +126.4% | -207.2% | +56.5% | -375.5% | +20.6% |
| 5 y | 5-year | -8.3% | +126.4% | -168.0% | +56.5% | -274.8% | +20.6% |
| alltime | all time | -82.3% | +118.3% | -125.5% | +94.2% | -125.8% | +82.0% |
Harvard Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.87 M(+3.0%) | -$5.69 M(+19.8%) |
| Jun 2024 | - | -$1.82 M(-20.1%) | -$4.75 M(+122.6%) |
| Mar 2024 | - | -$2.28 M(-908.2%) | -$2.13 M(-212.7%) |
| Dec 2023 | $1.89 M(-126.4%) | $282.00 K(-130.2%) | $1.89 M(+64.0%) |
| Sep 2023 | - | -$933.00 K(-217.2%) | $1.16 M(-152.1%) |
| Jun 2023 | - | $796.00 K(-54.5%) | -$2.22 M(-43.1%) |
| Mar 2023 | - | $1.75 M(-482.7%) | -$3.90 M(-45.6%) |
| Dec 2022 | -$7.17 M(-446.9%) | -$457.00 K(-89.4%) | -$7.17 M(+43.0%) |
| Sep 2022 | - | -$4.31 M(+388.2%) | -$5.01 M(+3111.5%) |
| Jun 2022 | - | -$882.00 K(-42.0%) | -$156.00 K(-119.9%) |
| Mar 2022 | - | -$1.52 M(-189.5%) | $784.00 K(-62.1%) |
| Dec 2021 | $2.07 M(+834.8%) | $1.70 M(+210.0%) | $2.07 M(-33.8%) |
| Sep 2021 | - | $548.00 K(+844.8%) | $3.12 M(+13.3%) |
| Jun 2021 | - | $58.00 K(-124.3%) | $2.76 M(-15.3%) |
| Mar 2021 | - | -$239.00 K(-108.7%) | $3.25 M(+1372.9%) |
| Dec 2020 | $221.00 K(-88.0%) | $2.76 M(+1414.3%) | $221.00 K(-126.2%) |
| Sep 2020 | - | $182.00 K(-67.3%) | -$842.00 K(-56.4%) |
| Jun 2020 | - | $556.00 K(-117.0%) | -$1.93 M(+46.6%) |
| Mar 2020 | - | -$3.27 M(-293.3%) | -$1.32 M(-171.6%) |
| Dec 2019 | $1.84 M(+86.7%) | $1.69 M(-287.1%) | $1.84 M(-2.6%) |
| Sep 2019 | - | -$905.00 K(-177.4%) | $1.89 M(-48.8%) |
| Jun 2019 | - | $1.17 M(-1074.2%) | $3.68 M(+72.8%) |
| Mar 2019 | - | -$120.00 K(-106.9%) | $2.13 M(+116.5%) |
| Dec 2018 | $984.00 K(-255.0%) | $1.74 M(+95.7%) | $984.00 K(-356.3%) |
| Sep 2018 | - | $890.00 K(-333.0%) | -$384.00 K(-76.9%) |
| Jun 2018 | - | -$382.00 K(-69.8%) | -$1.66 M(+7.3%) |
| Mar 2018 | - | -$1.27 M(-438.5%) | -$1.55 M(+144.3%) |
| Dec 2017 | -$635.00 K(-44.1%) | $374.00 K(-195.9%) | -$635.00 K(-32.9%) |
| Sep 2017 | - | -$390.00 K(+45.0%) | -$946.00 K(+36.5%) |
| Jun 2017 | - | -$269.00 K(-23.1%) | -$693.00 K(-45.1%) |
| Mar 2017 | - | -$350.00 K(-655.6%) | -$1.26 M(+12.5%) |
| Dec 2016 | -$1.14 M(+22.7%) | $63.00 K(-146.0%) | -$1.12 M(+45.5%) |
| Sep 2016 | - | -$137.00 K(-83.7%) | -$772.00 K(-25.3%) |
| Jun 2016 | - | -$839.00 K(+299.5%) | -$1.03 M(+2361.9%) |
| Mar 2016 | - | -$210.00 K(-150.7%) | -$42.00 K(-95.5%) |
| Dec 2015 | -$925.00 K(-113.5%) | $414.00 K(-203.8%) | -$925.00 K(-242.3%) |
| Sep 2015 | - | -$399.00 K(-360.8%) | $650.00 K(-74.7%) |
| Jun 2015 | - | $153.00 K(-114.0%) | $2.57 M(-39.8%) |
| Mar 2015 | - | -$1.09 M(-155.0%) | $4.27 M(-37.5%) |
| Dec 2014 | $6.83 M(+85.4%) | $1.99 M(+30.7%) | $6.83 M(+14.0%) |
| Sep 2014 | - | $1.52 M(-17.9%) | $6.00 M(+20.3%) |
| Jun 2014 | - | $1.85 M(+26.0%) | $4.99 M(+29.3%) |
| Mar 2014 | - | $1.47 M(+27.8%) | $3.85 M(+4.5%) |
| Dec 2013 | $3.69 M(-54.7%) | $1.15 M(+125.7%) | $3.69 M(-54.3%) |
| Sep 2013 | - | $510.00 K(-29.5%) | $8.06 M(+7.5%) |
| Jun 2013 | - | $723.00 K(-44.6%) | $7.50 M(-7.0%) |
| Mar 2013 | - | $1.30 M(-76.4%) | $8.07 M(-0.9%) |
| Dec 2012 | $8.14 M | $5.53 M(<-9900.0%) | $8.14 M(+28.2%) |
| Sep 2012 | - | -$50.00 K(-103.9%) | $6.35 M(-10.5%) |
| Jun 2012 | - | $1.29 M(-6.7%) | $7.10 M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $1.38 M(-63.1%) | $8.30 M(-6.4%) |
| Dec 2011 | $8.87 M(-17.2%) | $3.73 M(+435.7%) | $8.87 M(+7.1%) |
| Sep 2011 | - | $697.00 K(-72.0%) | $8.28 M(-15.6%) |
| Jun 2011 | - | $2.49 M(+27.7%) | $9.81 M(+1.2%) |
| Mar 2011 | - | $1.95 M(-38.0%) | $9.69 M(-9.6%) |
| Dec 2010 | $10.72 M(+25.0%) | $3.14 M(+41.2%) | $10.72 M(+1.6%) |
| Sep 2010 | - | $2.23 M(-6.2%) | $10.55 M(+2.3%) |
| Jun 2010 | - | $2.37 M(-20.3%) | $10.31 M(+12.5%) |
| Mar 2010 | - | $2.98 M(-0.0%) | $9.17 M(+7.0%) |
| Dec 2009 | $8.57 M(-14.6%) | $2.98 M(+49.7%) | $8.57 M(-6.3%) |
| Sep 2009 | - | $1.99 M(+62.1%) | $9.15 M(+0.8%) |
| Jun 2009 | - | $1.23 M(-48.4%) | $9.08 M(-11.6%) |
| Mar 2009 | - | $2.38 M(-33.1%) | $10.27 M(+2.3%) |
| Dec 2008 | $10.04 M(+5.3%) | $3.56 M(+85.6%) | $10.04 M(+9.1%) |
| Sep 2008 | - | $1.92 M(-20.7%) | $9.20 M(-0.9%) |
| Jun 2008 | - | $2.42 M(+12.6%) | $9.28 M(-1.5%) |
| Mar 2008 | - | $2.15 M(-20.9%) | $9.42 M(-1.2%) |
| Dec 2007 | $9.53 M(+9.7%) | $2.72 M(+35.8%) | $9.53 M(+4.6%) |
| Sep 2007 | - | $2.00 M(-21.7%) | $9.11 M(+1.5%) |
| Jun 2007 | - | $2.56 M(+13.0%) | $8.98 M(+3.0%) |
| Mar 2007 | - | $2.26 M(-1.5%) | $8.71 M(+0.2%) |
| Dec 2006 | $8.69 M(+9.7%) | $2.30 M(+23.4%) | $8.69 M(-2.3%) |
| Sep 2006 | - | $1.86 M(-18.7%) | $8.90 M(-5.5%) |
| Jun 2006 | - | $2.29 M(+2.2%) | $9.42 M(+9.0%) |
| Mar 2006 | - | $2.24 M(-10.5%) | $8.64 M(+9.1%) |
| Dec 2005 | $7.92 M(-5.5%) | $2.50 M(+5.0%) | $7.92 M(+6.9%) |
| Sep 2005 | - | $2.38 M(+57.4%) | $7.41 M(-0.6%) |
| Jun 2005 | - | $1.51 M(-0.3%) | $7.46 M(+13.9%) |
| Mar 2005 | - | $1.52 M(-23.8%) | $6.55 M(+26.1%) |
| Dec 2004 | $8.38 M(+9.4%) | $2.00 M(-17.9%) | $5.19 M(-10.9%) |
| Sep 2004 | - | $2.43 M(+300.2%) | $5.83 M(+14.5%) |
| Jun 2004 | - | $607.00 K(+272.4%) | $5.09 M(-22.9%) |
| Mar 2004 | - | $163.00 K(-93.8%) | $6.61 M(-13.8%) |
| Dec 2003 | $7.67 M(+92.8%) | $2.63 M(+55.6%) | $7.66 M(+40.3%) |
| Sep 2003 | - | $1.69 M(-20.2%) | $5.46 M(+17.5%) |
| Jun 2003 | - | $2.12 M(+73.5%) | $4.65 M(+15.8%) |
| Mar 2003 | - | $1.22 M(+183.3%) | $4.02 M(+1.0%) |
| Dec 2002 | $3.98 M(+405.6%) | $431.00 K(-51.0%) | $3.98 M(+8.5%) |
| Sep 2002 | - | $880.00 K(-40.7%) | $3.67 M(+30.5%) |
| Jun 2002 | - | $1.49 M(+25.6%) | $2.81 M(+93.7%) |
| Mar 2002 | - | $1.18 M(+898.3%) | $1.45 M(+62.2%) |
| Dec 2001 | $786.40 K(-107.6%) | $118.40 K(+393.3%) | $894.40 K(-102.8%) |
| Sep 2001 | - | $24.00 K(-81.0%) | -$31.62 M(+30.2%) |
| Jun 2001 | - | $126.00 K(-79.9%) | -$24.29 M(+42.4%) |
| Mar 2001 | - | $626.00 K(-101.9%) | -$17.06 M(+65.2%) |
| Dec 2000 | -$10.33 M(-1011.1%) | -$32.40 M(-540.4%) | -$10.33 M(-146.8%) |
| Sep 2000 | - | $7.36 M(0.0%) | $22.07 M(+50.0%) |
| Jun 2000 | - | $7.36 M(0.0%) | $14.71 M(+100.0%) |
| Mar 2000 | - | $7.36 M | $7.36 M |
| Dec 1999 | $1.13 M(-53.0%) | - | - |
| Dec 1998 | $2.41 M | - | - |
FAQ
- What is Harvard Bioscience annual operating income?
- What is the all time high annual operating profit for Harvard Bioscience?
- What is Harvard Bioscience annual operating profit year-on-year change?
- What is Harvard Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for Harvard Bioscience?
- What is Harvard Bioscience quarterly operating profit year-on-year change?
- What is Harvard Bioscience TTM operating income?
- What is the all time high TTM operating profit for Harvard Bioscience?
- What is Harvard Bioscience TTM operating profit year-on-year change?
What is Harvard Bioscience annual operating income?
The current annual operating profit of HBIO is $1.89 M
What is the all time high annual operating profit for Harvard Bioscience?
Harvard Bioscience all-time high annual operating income is $10.72 M
What is Harvard Bioscience annual operating profit year-on-year change?
Over the past year, HBIO annual operating income has changed by +$9.06 M (+126.43%)
What is Harvard Bioscience quarterly operating income?
The current quarterly operating profit of HBIO is -$1.87 M
What is the all time high quarterly operating profit for Harvard Bioscience?
Harvard Bioscience all-time high quarterly operating income is $7.36 M
What is Harvard Bioscience quarterly operating profit year-on-year change?
Over the past year, HBIO quarterly operating income has changed by -$941.00 K (-100.86%)
What is Harvard Bioscience TTM operating income?
The current TTM operating profit of HBIO is -$5.69 M
What is the all time high TTM operating profit for Harvard Bioscience?
Harvard Bioscience all-time high TTM operating income is $22.07 M
What is Harvard Bioscience TTM operating profit year-on-year change?
Over the past year, HBIO TTM operating income has changed by -$6.85 M (-592.73%)